Although Peru was a testing ground for more than one vaccine, the country still awaits clarity as to when it will be able to establish a mass-vaccination programme. Meanwhile, the facts and figures of the second wave of the Covid-19 portray an increasingly dire situation with much of the country back into severe lockdown.
The first batch of Sinopharm vaccines was supposed to arrive on 9 February from China. However, logistical problems arising from the suspension of flights led to doubts as to exact timing. KLM, which was supposed to have transported a million doses from China, has suspended flights for the time being; Air France appears to have stepped in. An initial batch of 300,000 doses are now promised for 7 February, with 700,000 more a week later.
Beyond this initial offering, Peru is also counting on deliveries under the World Health Organization’s Covax Facility scheme. These will consist of 117,000 doses of the Pfizer/BioNTech and 653,000 doses of the Oxford/AstraZeneca vaccines. The date of eventual arrival is still far from clear since some of the necessary paperwork still needs to be completed. Peru is one of four countries which will receive a pilot project of doses of the Pfizer vaccine (along with Bolivia, Colombia and El Salvador).
Delays in the supply of vaccine, the only way out of an increasingly grim second wave of the pandemic, appears to be affecting the interim government’s standing and authority. The latest IEP poll shows that support for Francisco Sagasti has diminished very rapidly since he took over as president in November.
Peru compares poorly with some of its neighbours which have now received some, albeit inadequate supplies, to help them vaccinate their population. Ecuador has received a small quantity of Pfizer vaccine with which at least to help vaccinate health workers. Bolivia has also received 20,000 doses of the Russian-made Sputnik V vaccine.
While the delay may give the Peruvian authorities time in which to plan a vaccination strategy, the distribution of available vaccines – particularly to more vulnerable populations – is likely to present formidable difficulties. In this respect, the Pfizer vaccine, which needs to be stored at extremely low temperatures, is likely to prove particularly problematic.
The second wave of the pandemic is putting huge strain on Peru’s deficient public health system. According to Heath Minister Pilar Mazzetti “the figures have been rising in the last four weeks [as fast as they did] in practically two months during the previous episode”. Demand for oxygen has increased by 200%. The death rate at the beginning of February was close to the maximum previously reached last June. Additionally, Mazzetti has confirmed the presence in Peru of the Brazilian variant of the virus which is thought to spread much faster than the original one.
Recent Comments